Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30

$3.92−0.08 (-2.00%)

Close on Nov 13, 2026Market cap $50.37MP/E –Yield –

Clene profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Clene's profit margin for the twelve months ending Sep 30, 2026 was -11271.4%. For fiscal 2025 it was -13086.5%, against -11520.5% the year before. The highest annual figure on record is -1347.2% in fiscal 2021.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-13086.5%	−1566.0
FY2024	Dec 31, 2024	-11520.5%	−3951.0
FY2023	Dec 31, 2023	-7569.4%	−1244.3
FY2022	Dec 31, 2022	-6325.2%	−4978.0
FY2021	Dec 31, 2021	-1347.2%	+8010.6
FY2020	Dec 31, 2020	-9357.8%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	6991.1%	+65504.4
Q2 FY2026	Jun 30, 2026	-14915.6%	+12562.2
Q1 FY2026	Mar 31, 2026	-53940.0%	−53012.8
Q4 FY2025	Dec 31, 2025	-11981.8%	+2907.2
Q3 FY2025	Sep 30, 2025	-58513.3%	−49334.0
Q2 FY2025	Jun 30, 2025	-27477.8%	−20021.7
Q1 FY2025	Mar 31, 2025	-927.2%	+14250.9
Q4 FY2024	Dec 31, 2024	-14889.0%	−8904.9
Q3 FY2024	Sep 30, 2024	-9179.3%	−6940.4
Q2 FY2024	Jun 30, 2024	-7456.0%	+1890.8
Q1 FY2024	Mar 31, 2024	-15178.1%	−4178.1
Q4 FY2023	Dec 31, 2023	-5984.1%	+6970.2
Q3 FY2023	Sep 30, 2023	-2238.9%	+42274.4
Q2 FY2023	Jun 30, 2023	-9346.8%	−11569.5
Q1 FY2023	Mar 31, 2023	-11000.0%	−37312.7
Q2 FY2022	Jun 30, 2022	-12954.3%	−11287.1
Q1 FY2022	Mar 31, 2022	-44513.3%	−25848.5
Q4 FY2021	Dec 31, 2021	2222.6%	−460.1
Q3 FY2021	Sep 30, 2021	26312.7%	+36817.8
Q2 FY2021	Jun 30, 2021	-1667.2%	+62988.4
Q1 FY2021	Mar 31, 2021	-18664.8%	−13034.8
Q4 FY2020	Dec 31, 2020	2682.8%	–
Q3 FY2020	Sep 30, 2020	-10505.1%	–
Q2 FY2020	Jun 30, 2020	-64655.6%	–
Q1 FY2020	Mar 31, 2020	-5630.0%	–